The Elderly International Prognostic Index (E-IPI) is used to evaluate older adults with diffuse large B-cell lymphoma (DLBCL).
Patient selection: diffuse large B-cell lymphoma with age > 60 years.
Parameters:
(1) age of the patient in years
(2) serum LDH in U/L relative to the upper limit of the normal reference range (ULN)
(3) ECOG performance status
(4) Ann Arbor stage
(5) extranodal sites
Parameter |
Finding |
Points |
age of the patient |
< 70 years |
0 |
|
>= 70 yeaers |
1 |
serum LDH |
<= ULN |
0 |
|
> ULN |
1 |
ECOG performance |
0 or 1 |
0 |
|
2 to 4 |
1 |
Ann Arbor stage |
I or II |
0 |
|
III or IV |
1 |
extranodal sites |
0 |
0 |
|
>= 1 |
1 |
where:
• Risk factors differ from the IPI with age and extranodal sites.
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 5
Elderly IPI Score |
Risk Group |
3-Year Overall Survival |
0 or 1 |
low |
86% |
2 |
low-intermediate |
74% |
3 |
high-intermediate |
58% |
4 or 5 |
high |
36% |
Specialty: Hematology Oncology